These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31482621)

  • 1. Effectiveness of two-drug therapy versus monotherapy as initial regimen in hypertension: A propensity score-matched cohort study in the UK Clinical Practice Research Datalink.
    Marinier K; Macouillard P; de Champvallins M; Deltour N; Poulter N; Mancia G
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1572-1582. PubMed ID: 31482621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study.
    Gradman AH; Parisé H; Lefebvre P; Falvey H; Lafeuille MH; Duh MS
    Hypertension; 2013 Feb; 61(2):309-18. PubMed ID: 23184383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data.
    Sinnott SJ; Smeeth L; Williamson E; Perel P; Nitsch D; Tomlinson LA; Douglas IJ
    Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1267-1277. PubMed ID: 31313390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line combination therapy versus first-line monotherapy for primary hypertension.
    Garjón J; Saiz LC; Azparren A; Elizondo JJ; Gaminde I; Ariz MJ; Erviti J
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010316. PubMed ID: 28084624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapy. A randomized trial: the EDICTA study.
    Ruilope LM; de la Sierra A; Moreno E; Fernández R; Garrido J; de la Figuera M; de la Cámara AG; Coca A; Luque-Otero M
    J Hypertens; 1999 Dec; 17(12 Pt 2):1917-23. PubMed ID: 10703890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.
    Everett BM; Glynn RJ; Danielson E; Ridker PM;
    Clin Ther; 2008 Apr; 30(4):661-72. PubMed ID: 18498915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of incretin-based therapies and the risk of death and cardiovascular events in 38,233 metformin monotherapy users.
    Gamble JM; Thomas JM; Twells LK; Midodzi WK; Majumdar SR
    Medicine (Baltimore); 2016 Jun; 95(26):e3995. PubMed ID: 27368005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005-2016.
    Derington CG; King JB; Herrick JS; Shimbo D; Kronish IM; Saseen JJ; Muntner P; Moran AE; Bress AP
    Hypertension; 2020 Apr; 75(4):973-981. PubMed ID: 32148129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy.
    Weber MA; Julius S; Kjeldsen SE; Jia Y; Brunner HR; Zappe DH; Hua TA; McInnes GT; Schork A; Mancia G; Zanchetti A
    J Hypertens; 2012 Nov; 30(11):2213-22. PubMed ID: 23011525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studies.
    Nash DT; Crikelair N; Zappe D
    Curr Med Res Opin; 2008 Sep; 24(9):2617-26. PubMed ID: 18687165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial monotherapy and combination therapy and hypertension control the first year.
    Egan BM; Bandyopadhyay D; Shaftman SR; Wagner CS; Zhao Y; Yu-Isenberg KS
    Hypertension; 2012 Jun; 59(6):1124-31. PubMed ID: 22566499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription pattern of anti-hypertensive drugs in a tertiary health institution in Nigeria.
    Etuk E; Isezuo SA; Chika A; Akuche J; Ali M
    Ann Afr Med; 2008 Sep; 7(3):128-32. PubMed ID: 19253522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of antihypertensive medications among physicians and its impact on blood pressure control among Nigerians living with hypertension.
    Mijinyawa Muhammad S; Yusuf MS; Mohammed H; Saidu H; Sulaiman BA; Uloko AE
    Niger J Med; 2016; 25(3):220-5. PubMed ID: 30011166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.